1. Home
  2. NBY vs VTAK Comparison

NBY vs VTAK Comparison

Compare NBY & VTAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBY
  • VTAK
  • Stock Information
  • Founded
  • NBY 2000
  • VTAK 2002
  • Country
  • NBY United States
  • VTAK United States
  • Employees
  • NBY N/A
  • VTAK N/A
  • Industry
  • NBY
  • VTAK Medical/Dental Instruments
  • Sector
  • NBY
  • VTAK Health Care
  • Exchange
  • NBY Nasdaq
  • VTAK Nasdaq
  • Market Cap
  • NBY 3.8M
  • VTAK 3.9M
  • IPO Year
  • NBY 2007
  • VTAK 2018
  • Fundamental
  • Price
  • NBY $0.91
  • VTAK $3.04
  • Analyst Decision
  • NBY Strong Buy
  • VTAK
  • Analyst Count
  • NBY 1
  • VTAK 0
  • Target Price
  • NBY $0.85
  • VTAK N/A
  • AVG Volume (30 Days)
  • NBY 9.7M
  • VTAK 3.1M
  • Earning Date
  • NBY 08-14-2025
  • VTAK 08-11-2025
  • Dividend Yield
  • NBY N/A
  • VTAK N/A
  • EPS Growth
  • NBY N/A
  • VTAK N/A
  • EPS
  • NBY 0.41
  • VTAK N/A
  • Revenue
  • NBY $9,781,000.00
  • VTAK $600,000.00
  • Revenue This Year
  • NBY $23.91
  • VTAK $822.86
  • Revenue Next Year
  • NBY $32.05
  • VTAK $168.42
  • P/E Ratio
  • NBY $2.69
  • VTAK N/A
  • Revenue Growth
  • NBY 113.47
  • VTAK 37.62
  • 52 Week Low
  • NBY $0.44
  • VTAK $2.49
  • 52 Week High
  • NBY $1.25
  • VTAK $43.70
  • Technical
  • Relative Strength Index (RSI)
  • NBY 66.42
  • VTAK 44.02
  • Support Level
  • NBY $0.88
  • VTAK $2.70
  • Resistance Level
  • NBY $1.25
  • VTAK $4.31
  • Average True Range (ATR)
  • NBY 0.08
  • VTAK 0.37
  • MACD
  • NBY 0.04
  • VTAK 0.03
  • Stochastic Oscillator
  • NBY 52.14
  • VTAK 30.22

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

Share on Social Networks: